Showing results (561-570 of 668) with videos related to

Sort By:
Pageof 67
Practical Radiation Oncology|June 28, 2016
Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastasesHania A Al-Hallaq, Steven Chmura, Joseph K Salama, et al.
Mabs|October 3, 2015
Generation and preclinical characterization of an antibody specific for SEMA4DTerrence L Fisher, Christine A Reilly, Laurie A Winter, et al.
European Journal of Cancer (Oxford, England : 1990)|October 2, 2019
Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC)Eleonor Rivin Del Campo, Oscar Matzinger, Karin Haustermans, et al.
Inflammatory Bowel Diseases|July 13, 2015
Pediatric IBD-unclassified Is Less Common than Previously Reported; Results of an 8-Year Audit of the EUROKIDS RegistryDwight A Winter, Katarzyna Karolewska-Bochenek, Izabella Lazowska-Przeorek, et al.
International Journal of Cardiology|May 27, 2014
Dose matters! Optimisation of guideline adherence is associated with lower mortality in stable patients with chronic heart failureG Poelzl, J Altenberger, R Pacher, et al.
Cancer Biology & Therapy|March 13, 2014
dCK expression correlates with 5-fluorouracil efficacy and HuR cytoplasmic expression in pancreatic cancer: a dual-institutional follow-up with the RTOG 9704 trialFlorencia McAllister, Danielle M Pineda, Masaya Jimbo, et al.
Blood Cancer Journal|April 15, 2025
Outcomes of patients with relapsed/refractory lymphoplasmacytic lymphoma/waldenström macroglobulinemia treated with venetoclax: a multicenter retrospective analysisY Sawalha, S Sarosiek, R L Welkie, et al.
International Journal of Radiation Oncology, Biology, Physics|August 29, 2020
Impact of Diabetes and Insulin Use on Prognosis in Patients With Resected Pancreatic Cancer: An Ancillary Analysis of NRG Oncology RTOG 9704Danielle S Bitterman, Kathryn A Winter, Theodore S Hong, et al.
Cancer Immunology Research|January 24, 2015
Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory TherapiesElizabeth E Evans, Alan S Jonason, Holm Bussler, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2006
Potent benzimidazolone based human beta(3)-adrenergic receptor agonistsDon R Finley, Michael G Bell, Anthony G Borel, et al.
Pageof 67